CytomX Therapeutics Inc.
CTMX
|
|
| |
|
| Trading Volume | 8,818 |
|
|
2.74 - 1.07 |
| Market Cap Full | $ 77.7M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 10.8% | 37.4% | -5.6% | -37.4% |
| Q2 | - | -41.4% | 13.9% | -32.5% |
| Q3 | - | -16.3% | -25% | -20.8% |
| Q4 | - | -1.9% | 24% | 10.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.8 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -1.3 | 60.1 | -13.1 | -21.6 | 1.8 | -25.9 | 9.5 | -16.3 | - | - | - | -4.3 |
| 2023 | |||||||||||
| 68.8 | -20.4 | -29.8 | 8 | 4.9 | 0.6 | 1.2 | -13.8 | -14 | -14.7 | 26.4 | 11.5 |
| 2022 | |||||||||||
| 6.2 | -16.7 | -29.2 | -36.9 | -5.9 | 13.7 | -21.9 | 4.9 | -3.3 | -9.7 | 32.8 | -8.1 |
| 2021 | |||||||||||
| 5.5 | 13.6 | -1.5 | 21.1 | -23.5 | -11.6 | -14.5 | -5.4 | -0.6 | 15.8 | 12.1 | -34.5 |
| 2020 | |||||||||||
| -11.7 | -13 | 18.9 | 34.6 | -14.2 | -6 | -15.9 | 4.2 | -9 | 1.7 | 11.2 | -12.9 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.1 | -0.4 | -0.3 | 0.3 |
| Q2 | -0 | -0.4 | -0.3 | -0.3 |
| Q3 | 0 | -0.4 | -0.4 | -0.3 |
| Q4 | 0 | -0.4 | -0.9 | -0.3 |
| A | -0.03 | -1.5 | -1.8 | -0.7 |